Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-25
2005-01-25
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S399000, C544S400000
Reexamination Certificate
active
06846824
ABSTRACT:
Compounds of formula (I)its tautomeric forms, its stereoisomers, its polymorphs, its pharmaceutically acceptable salts or its pharmaceutically acceptable solvates can be used to prevent or treat diabetes caused by insulin resistance or impaired glucose tolerance or complications of diabetes caused by insulin resistance or impaired glucose tolerance. The compounds can also be used to reduce cholesterol, body weight, blood glucose, triglycerides and free fatty acids in the blood.
REFERENCES:
patent: 5104888 (1992-04-01), Yoshioka
patent: 5227490 (1993-07-01), Hartman
patent: 5306726 (1994-04-01), Hulin
patent: 5648368 (1997-07-01), Egbertson et al.
patent: 5696117 (1997-12-01), Frechette et al.
patent: 0441539 (1991-08-01), None
patent: 0903343 (1998-03-01), None
patent: 0903343 (1998-09-01), None
patent: 9119702 (1991-12-01), None
patent: 9517394 (1991-12-01), None
patent: 9401420 (1994-01-01), None
patent: 9604260 (1994-01-01), None
patent: 9413650 (1994-06-01), None
patent: 9507697 (1995-03-01), None
patent: 9725042 (1995-06-01), None
patent: 9535108 (1995-12-01), None
patent: 9741097 (1997-11-01), None
patent: 0140159 (2001-06-01), None
patent: 0140165 (2001-06-01), None
patent: 0140166 (2001-06-01), None
patent: 0140169 (2001-06-01), None
patent: 0140170 (2001-06-01), None
patent: 0140171 (2001-06-01), None
patent: 0140172 (2001-06-01), None
patent: 0153257 (2001-07-01), None
Patent abstracts of Japan vol. 17, NO.627(C11-31) l+9 Nov.1993& JP 05 194236A.
Buckle, D.R. “Non Thiazolidinedione Antihyperglyceaamic Agents . . . ” Bioorganic & Medicinal Chemistry Letters, vol.6, NO.17, pp. 2121-2126, 1996.
Hulin, B. “Hypolycemic Activity of a Series of . . . ” J. Med. Chem. 36, 1996, pp. 3897-3907.
Patent Abstracts of Japan vol.97, NO.5, May 30, 1997 & JP 09 012575, Jan. 14, 1997.
Messier et al. Glucose Regulation and Cognitive Functions, Behaviourial Brain Research. 75, 1-11, May 31, 1995.
Modan et al. Hyperinsulinemia. J. Clin. Invest. 75, 809-817, Mar. 1985.
Koltterman et al. Receptor and Postreceptor Defects . . . J. Clin. Invest. 68, 057-969, Oct. 1981.
Ferrannini et al. Insulin Resistance in Essential Hypertension, New England J. Medicine 317,350-357, Aug. 1987.
Bailey, Potential Treatments for Type-2 Diabetes. Chemistry & Industry, 53-57, Jan. 1998.
Shen et al. Resistance to Insulin . . . J. Clin. Ecdocrinol. Metab. 66, 580-583, Mar. 1988.
Bajji Ashok Channaveerappa
Chakrabarti Ranjan
Gurram Ranga Madhavan
Iqbal Javed
Kalchar Shivaramayya
Dr. Reddy's Laboratories Ltd.
Ladas & Parry
Raymond Richard L.
LandOfFree
Bicyclic compounds and their use in medicine; process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic compounds and their use in medicine; process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compounds and their use in medicine; process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3391448